An unmet challenge of primary plasma cell leukemia: A systematic review of its unique biology, efficacy of conventional, and high dose therapy.

e20048Background: Primary plasma cell leukemia (pPCL) is rare but aggressive disease with median overall survival (mOS) of less than one year. Our aim is to review its unique biology, efficacy of a...